Growth Metrics

Omeros (OMER) EPS (Basic) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 209.23%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 209.23%
Dec 31, 2025 358.18%
Sep 30, 2025 16.07%
Jun 30, 2025 55.67%
Mar 31, 2025 -3.17%
Dec 31, 2024 -296.43%
Sep 30, 2024 6.67%
Jun 30, 2024 -38.57%
Mar 31, 2024 0.00%
Dec 31, 2023 -86.41%
Sep 30, 2023 31.03%
Jun 30, 2023 -6.06%
Mar 31, 2023 0.00%
Dec 31, 2022 374.67%
Sep 30, 2022 -141.67%
Jun 30, 2022 17.50%
Mar 31, 2022 22.22%
Dec 31, 2021 -25.00%
Sep 30, 2021 45.45%
Jun 30, 2021 -31.15%
Mar 31, 2021 -52.83%
Dec 31, 2020 -3.45%
Sep 30, 2020 -100.00%
Jun 30, 2020 -110.34%
Mar 31, 2020 -6.00%
Dec 31, 2019 -20.83%
Sep 30, 2019 59.26%
Jun 30, 2019 58.57%
Mar 31, 2019 19.35%
Dec 31, 2018 -41.18%
Sep 30, 2018 -406.25%
Jun 30, 2018 -112.12%
Mar 31, 2018 -82.35%
Dec 31, 2017 24.44%
Sep 30, 2017 52.94%
Jun 30, 2017 -3.13%
Mar 31, 2017 37.04%
Dec 31, 2016 13.46%
Sep 30, 2016 35.85%
Jun 30, 2016 27.27%
Mar 31, 2016 -5.88%
Dec 31, 2015 14.75%
Sep 30, 2015 1.85%
Jun 30, 2015 16.98%
Mar 31, 2015 5.56%
Dec 31, 2014 -1,120.00%
Sep 30, 2014 -17.39%
Jun 30, 2014 -10.42%
Mar 31, 2014 -35.00%
Dec 31, 2013 83.33%
Sep 30, 2013 9.80%
Jun 30, 2013 -26.32%
Mar 31, 2013 0.00%
Dec 31, 2012 34.78%
Sep 30, 2012 -75.86%
Jun 30, 2012 -58.33%
Mar 31, 2012 -33.33%
Dec 31, 2011 -35.29%
Sep 30, 2011 17.14%
Jun 30, 2011 33.33%